Work in the Ruffell lab is/was generously funded by

Ongoing Research Support

Cancer Research Institute

Targeting dendritic cells to improve cancer immunotherapy

Targeting ENPP1 to promote immunity during PARP inhibition in TNBC

Regulation of dendritic cell function and tumor immunity by TIM-3

Previous Research Support

The Mike Slive Foundation

Evaluating TIM-3 combination therapies in castration-resistant prostate cancer

DOD/CDMRP Breast Cancer Research Program W81XWH-20-1-0012

Breast cancer immunotherapy with anti-TIM-3

Florida Department of Health Bankhead-Coley Cancer Research Program 8BC02

Regulation of dendritic cell function and tumor immunity by TIM-3

Florida Breast Cancer Foundation

Targeting the immune checkpoint molecule TIM-3 in breast cancer

Regulating intratumoral leukocytes to improve response to chemotherapy

The Shula Fund @ Moffitt Cancer Center

Immunotherapy and intratumoral dendritic cells in breast cancer

Funding